SKK
JNP

Shepherd Kaplan Krochuk’s Juniper Pharmaceuticals, Inc. Common Stock JNP Stock Holding History

Shepherd Kaplan Krochuk’s Portfolio JNP Stock Details JNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-20,433
Closed -$127K – 470
2015
Q1 		$127K Sell
20,433
-5,300
-21% -$32.8K 0.02% 334
2014
Q4 		$144K Buy
+25,733
New +$150K 0.02% 391

Other funds holding JNP

JAM
JW Asset Management Miami Beach, Florida $244M AUM 71.51% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PCM
Perritt Capital Management Chicago, Illinois $59.8M AUM 26.94% 1-Year Est. Return
CCM
Cadence Capital Management Boston, Massachusetts $415M AUM 11.01% 1-Year Est. Return
GF
Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
BAMS
Bellevue Asset Management (Switzerland) Kuesnacht, Switzerland $656M AUM 11.45% 1-Year Est. Return

Shepherd Kaplan Krochuk's JNP Position: Q2 2015 in Review

Shepherd Kaplan Krochuk sold out of Juniper Pharmaceuticals, Inc. Common Stock (JNP) in Q2 2015, closing a stake of 20,433 shares — an estimated $127K sold.

Shepherd Kaplan Krochuk first reported a position in JNP in Q4 2014 and held it in 2 quarters. The position peaked at $144K in Q4 2014. 44 funds tracked by Wall St. Rank hold JNP as of Q2 2015.

  • Shepherd Kaplan Krochuk reported no remaining Juniper Pharmaceuticals, Inc. Common Stock position as of Q2 2015 after selling out during the quarter.
  • Shepherd Kaplan Krochuk sold 20,433 Juniper Pharmaceuticals, Inc. Common Stock shares in Q2 2015, an estimated $127K.
  • Shepherd Kaplan Krochuk first reported a position in Juniper Pharmaceuticals, Inc. Common Stock in Q4 2014 and held it in 2 quarters.
  • Shepherd Kaplan Krochuk's Juniper Pharmaceuticals, Inc. Common Stock position peaked at $144K in Q4 2014.
  • 44 funds tracked by Wall St. Rank held Juniper Pharmaceuticals, Inc. Common Stock as of Q2 2015.

Based on Shepherd Kaplan Krochuk's 13F filing for Q2 2015, filed 14 Aug 2015.